NCT05634447

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391

A Phase I Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics After Administration of CKD-391 and Co-administration of CKD-331 and D337 in Healthy Adult Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 69 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-391

Detailed description

A phase I clinical trial to compare and evaluate the safety and pharmacokinetic characteristics after administration of CKD-391 and co-administration of CKD-331 and D337 in healthy adult volunteers

Conditions

• Dyslipidemias

Interventions

Type	Name	Description
DRUG	Drug: CKD-391, QD, PO	Drug: CKD-331, D337 QD, PO

Timeline

• Start date: 2022-12-20
• Primary completion: 2023-02-27
• Completion: 2023-06-07
• First posted: 2022-12-02
• Last updated: 2023-10-06

Locations

1 site across 1 country: South Korea